Tag: Biotech and Pharma

 Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of strong sales for its blockbuster cancer drug Keytruda, sending the company’s shares up more than 2% before the bell.

Στις θετικές προοπτικές που διανοίγονται τόσο για φέτος, όσο και για τα επόμενα χρόνια, αναφέρθηκε η διοίκηση της Lavipharm-1,05% στο πλαίσιο της χθεσινής παρουσίασης της εισηγμένης εταιρείας στην Ένωση Θεσμικών Επενδυτών.

Biogen reported first-quarter profit that topped estimates as the company’s cost-cutting efforts took hold and sales of its closely watched Alzheimer’s drug, Leqembi, came in higher than expected.

Shares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals on Tuesday, after the company raised its full-year guidance following better-than-expected first-quarter results.

 Drugmaker Bristol Myers Squibb said it has signed a $380 million deal with contract manufacturer Cellares to manufacture its CAR-T cell therapies in the United States, EU and Japan.

Shares of Cardinal Health were falling after the drug maker said it won’t be renewing a distribution contract with pharmacy benefits manager OptumRx.

Eli Lilly on Wednesday said its highly popular weight loss drug Zepbound showed the potential to treat patients with the most common sleep-related breathing disorder in two late-stage clinical trials.

Johnson & Johnson reported first-quarter adjusted earnings that topped expectations as sales in its medical devices business surged.

Johnson & Johnson  agreed to acquire medical-devices maker Shockwave Medical  for a total enterprise value of about $13.1 billion.

Moderna announced positive clinical trial data on three experimental vaccines and said it will move those shots to final stage studies.

The FDA approved a drug from Merck designed to treat a rare, progressive and life-threatening lung condition called pulmonary arterial hypertension.

Eli Lilly said Amazon Pharmacy will help deliver certain prescription drugs, including the popular weight loss treatment Zepbound, directly to patients’ homes through the drugmaker’s new direct-to-consumer website. 

The company told an investor meeting that the Phase I trial of its highly-anticipated obesity drug amycretin showed a 13.1% weight loss in participants after 12 weeks, according to Reuters.

Η LavipharmΛΑΒΙ -0,64% A.E. ανακοίνωσε ότι οι ενοποιημένες Πωλήσεις από συνεχιζόμενη δραστηριότητα προ Rebate & Clawback ανήλθαν σε Ευρώ 57,43 εκατ. το 2023 έναντι Ευρώ 45,14 εκατ. κατά τη χρήση 2022, παρουσιάζοντας αύξηση κατά 27,2%.

Vaccine maker Novavax on Wednesday reported fourth-quarter revenue and earnings that missed Wall Street’s estimates and reiterated plans to cut costs as it fights to stay afloat. 

Patients saw “significant” reductions in body weight during a study of a weight-loss drug developed by Viking Therapeutics sending shares of the biopharmaceutical company soaring in premarket trading Tuesday.

Shares of Denmark’s Zealand Pharma shot 32% higher in morning trade, after results showed success in its liver disease treatment survodutide, which is also on trial as a drug to treat obesity.

Moderna posted a surprise quarterly profit, in part boosted by deferred revenue, even as the company saw slumping sales from its Covid vaccine, its only marketable product. 

Ιστορική μέρα η σημερινή για την Lavipharm, καθώς 1,5 χρόνο μετά την αύξηση κεφαλαίου που άλλαξε τον ρου της εισηγμένης στη χρηματιστηριακή θάλασσα, γίνεται πράξη η είσοδό της στην φαρμακευτική κάνναβη και όλα δείχνουν πως πραγματώνεται ο στόχος για εκτίναξη των EBITDA ως το 2025.

Τη διακοπή της δραστηριότητας φαρμακαποθήκης και υπηρεσιών logistics προς τρίτους ανακοίνωσε η Lavipharm, καθώς και τη μεταβίβαση ορισμένων στοιχείων του ενεργητικού της θυγατρικής της εταιρείας LAS στην Profarm.